|
|
|
|
|
|
|
|
|
|
|
30.10.25 - 22:06
|
Aptar Reports Third Quarter 2025 Results (Business Wire)
|
|
|
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today reported the following third quarter results for the period ended September 30, 2025, as compared to the corresponding period of the last fiscal year.
Third Quarter 2025 Highlights
(Compared to the prior year quarter; see Non-GAAP section for full definitions; see reconciliation for Non-GAAP measures)
Reported sales increased 6% and core sales increased 1%
Strong product volume growth in Closures and Pharma, especially in injectables
Reported net income increased 28% to $128 million and reported earnings per share increased 30% to $1.92
Adjusted earnings per share, which also excludes non-ordinary-course litigation costs (see Non-GAAP section for full definition), increased 4% to $1.62
Adjusted EBITDA, which also excludes non-ordinary-course litigation costs, increased 7% to $223 million
Adjusted EBITDA margin was 23.2% compared to 22...
|
|
|
|
|
|
|
|
|
|
|
21.10.25 - 23:54
|
XFRA: DIVIDEND/INTEREST INFORMATION - 23.10.2025 - US0383361039 (XETRA)
|
|
|
Das Instrument AGT US0383361039 APTARGRP INC. DL-,01 EQUITY wird cum Dividende/Zinsen gehandelt am 22.10.2025 und ex Dividende/Zinsen am 23.10.2025
The instrument AGT US0383361039 APTARGRP INC. DL-,01 EQUITY has its pre-dividend/interest day on 22.10.2025 and its ex-dividend/interest day on 23.10.2025...
|
|
|
|
|
|
|
|
|
|
|
|
|
08.09.25 - 23:03
|
Aptar Increases Quarterly Dividend by Nearly 7% Signaling Continued Momentum and Long-Term Strength (Business Wire)
|
|
|
Following an increase of almost 10% a year agoCRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.48 per share, an almost 7% increase from the previous dividend amount, bringing the new annualized dividend to $1.92 per share. The payment date is November 13, 2025, to stockholders of record as of October 23, 2025.
Stephan B. Tanda, Aptar President and CEO, commented, “Given the strength of our business outlook, the sustained long-term growth we anticipate from our Pharma segment, and our continued strong performance across all key financial metrics, the Board of Directors has approved an increase in the quarterly dividend. Since 2020, we've returned over $1 billion to shareholders through dividends and share repurchases, and we remain on track to achieve our 32nd consecutive year of increasing our total annual dividend.”
As previously announced...
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
